Bullous pemphigoid, a rare blistering skin condition, is seen in a small percentage of cancer patients treated with immune checkpoint inhibitors and may also be a tumor response marker.
Medscape Medical News
Bullous pemphigoid, a rare blistering skin condition, is seen in a small percentage of cancer patients treated with immune checkpoint inhibitors and may also be a tumor response marker.
Medscape Medical News
